Global Blood Purification Devices Market

Blood Purification Devices Comprehensive Study by Type (Hemodialysis Device, Blood Filtration Device, Continuous Renal Replacement Therapy (CRRT) Device, Hemoperfusion Device, Plasma Exchange Device), Application (Hospitals & Clinics, Dialysis Centers, Others), Mobility (Portable, Stationary), End-Use (Sepsis, COVID-19, Infectious Diseases, Acute Kidney Injury, Others) Players and Region - Global Market Outlook to 2026

Blood Purification Devices Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Blood Purification Devices Market?

The demand for blood purification therapies has increased significantly over the past few decades and is increasingly being used to treat a variety of conditions that cannot be treated with conventional therapies, including surgery and drug delivery. The advances made by bioseparation techniques such as filtration, dialysis, and adsorption are one of the key factors that are expected to significantly fuel the expansion of the blood purification device market over the forecast period. Blood purification therapies offer a high level of efficiency in the quick and direct removal of pathogens, which further increases their acceptance in several regions of the world. At present, blood purification therapy is primarily used for three major clinical applications, such as plasmapheresis of toxins, life support for organ failure, including hemodialysis for renal failure, and treatment of immune and metabolic disorders, including immune adsorption for autoimmune diseases. The increasing prevalence of metabolic and autoimmune diseases such as kidney failure worldwide is one of the main drivers for the introduction of blood purification devices. A number of therapeutic advances in technology and new blood purification devices have been developed over the past few decades - a trend that is expected to continue over the forecast period.

The market study is being classified by Type (Hemodialysis Device, Blood Filtration Device, Continuous Renal Replacement Therapy (CRRT) Device, Hemoperfusion Device and Plasma Exchange Device), by Application (Hospitals & Clinics, Dialysis Centers and Others) and major geographies with country level break-up.

Asahi Kasei Medical (Japan), Haemonetics (United States), Toray Industries, Inc. (Japan), Macopharma (France), Cytosorbents Corporation (United States), Baxter International, Inc. (United States), B. Braun Melsungen AG (Germany), ExThera Medical Corporation (United States), Medtronic plc (Bellco) (Ireland), Aethlon Medical, Inc. (United States), Fresenius SE & Co. KGaA (Germany), Cerus Corporation (United States), Jafron Biomedical Co., Ltd. (China), Spectra Medical, Inc. (United States) and Kaneka Medix Corp (Japan) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Nikkiso Co, Ltd. (Japan), Shandong Zhongbaokang (China) and Nanjing Shuangwei (China).

The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Blood Purification Devices market throughout the predicted period.

Segment Analysis
Analyst at AMA have segmented the market study of Global Blood Purification Devices market by Type, Application and Region.

On the basis of geography, the market of Blood Purification Devices has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • The High Prevalence of Patients Suffering With Chronic Kidney Diseases
  • The Growing Adoption of Blood Filtration Therapies
  • High Demand for Blood and Blood Components for the Treatment
  • A Rise in High Degree of Efficiency in Rapid and Direct Removal of Pathogenic Agents

Market Trend
  • Rapidly Changing Health Care Infrastructure in Emerging Countries
  • The Rise in New Diagnostics and Medical Treatment Devices
  • Increasing Knowledge and Understanding of Pathophysiology and Hematology

Restraints
  • High Costs Associated With the Products

Opportunities
  • The Rising Development of Blood Filtration Technology
  • The Rising Development in the Healthcare Industry and Rising Healthcare Expenditures

Challenges
  • Lack of Access to Dialysis in Under Developed Regions


In August 2019, CytoSorbents Corporation announced that it had received approval for its CytoSorb from the European Union through May 2024 and ISO 13485: 2016 certification for its full quality system. The product is expected to be manufactured by September 2022.
In April 2020, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization for blood purification equipment to treat COVID-19 positive patients.

Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Manufactures of Blood Purification Devices, Suppliers and Distributors of Blood Purification Devices, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End-Use Industry

Report Objectives / Segmentation Covered

By Type
  • Hemodialysis Device
  • Blood Filtration Device
  • Continuous Renal Replacement Therapy (CRRT) Device
  • Hemoperfusion Device
  • Plasma Exchange Device
By Application
  • Hospitals & Clinics
  • Dialysis Centers
  • Others
By Mobility
  • Portable
  • Stationary

By End-Use
  • Sepsis
  • COVID-19
  • Infectious Diseases
  • Acute Kidney Injury
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. The High Prevalence of Patients Suffering With Chronic Kidney Diseases
      • 3.2.2. The Growing Adoption of Blood Filtration Therapies
      • 3.2.3. High Demand for Blood and Blood Components for the Treatment
      • 3.2.4. A Rise in High Degree of Efficiency in Rapid and Direct Removal of Pathogenic Agents
    • 3.3. Market Challenges
      • 3.3.1. Lack of Access to Dialysis in Under Developed Regions
    • 3.4. Market Trends
      • 3.4.1. Rapidly Changing Health Care Infrastructure in Emerging Countries
      • 3.4.2. The Rise in New Diagnostics and Medical Treatment Devices
      • 3.4.3. Increasing Knowledge and Understanding of Pathophysiology and Hematology
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Blood Purification Devices, by Type, Application, Mobility, End-Use and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Blood Purification Devices (Value)
      • 5.2.1. Global Blood Purification Devices by: Type (Value)
        • 5.2.1.1. Hemodialysis Device
        • 5.2.1.2. Blood Filtration Device
        • 5.2.1.3. Continuous Renal Replacement Therapy (CRRT) Device
        • 5.2.1.4. Hemoperfusion Device
        • 5.2.1.5. Plasma Exchange Device
      • 5.2.2. Global Blood Purification Devices by: Application (Value)
        • 5.2.2.1. Hospitals & Clinics
        • 5.2.2.2. Dialysis Centers
        • 5.2.2.3. Others
      • 5.2.3. Global Blood Purification Devices by: Mobility (Value)
        • 5.2.3.1. Portable
        • 5.2.3.2. Stationary
      • 5.2.4. Global Blood Purification Devices by: End-Use (Value)
        • 5.2.4.1. Sepsis
        • 5.2.4.2. COVID-19
        • 5.2.4.3. Infectious Diseases
        • 5.2.4.4. Acute Kidney Injury
        • 5.2.4.5. Others
      • 5.2.5. Global Blood Purification Devices Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Blood Purification Devices (Volume)
      • 5.3.1. Global Blood Purification Devices by: Type (Volume)
        • 5.3.1.1. Hemodialysis Device
        • 5.3.1.2. Blood Filtration Device
        • 5.3.1.3. Continuous Renal Replacement Therapy (CRRT) Device
        • 5.3.1.4. Hemoperfusion Device
        • 5.3.1.5. Plasma Exchange Device
      • 5.3.2. Global Blood Purification Devices by: Application (Volume)
        • 5.3.2.1. Hospitals & Clinics
        • 5.3.2.2. Dialysis Centers
        • 5.3.2.3. Others
      • 5.3.3. Global Blood Purification Devices by: Mobility (Volume)
        • 5.3.3.1. Portable
        • 5.3.3.2. Stationary
      • 5.3.4. Global Blood Purification Devices by: End-Use (Volume)
        • 5.3.4.1. Sepsis
        • 5.3.4.2. COVID-19
        • 5.3.4.3. Infectious Diseases
        • 5.3.4.4. Acute Kidney Injury
        • 5.3.4.5. Others
      • 5.3.5. Global Blood Purification Devices Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Blood Purification Devices (Price)
      • 5.4.1. Global Blood Purification Devices by: Type (Price)
  • 6. Blood Purification Devices: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Asahi Kasei Medical (Japan)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Haemonetics (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Toray Industries, Inc. (Japan)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Macopharma (France)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Cytosorbents Corporation (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Baxter International, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. B. Braun Melsungen AG (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. ExThera Medical Corporation (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Medtronic plc (Bellco) (Ireland)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Aethlon Medical, Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Fresenius SE & Co. KGaA (Germany)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Cerus Corporation (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Jafron Biomedical Co., Ltd. (China)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
      • 6.4.14. Spectra Medical, Inc. (United States)
        • 6.4.14.1. Business Overview
        • 6.4.14.2. Products/Services Offerings
        • 6.4.14.3. Financial Analysis
        • 6.4.14.4. SWOT Analysis
      • 6.4.15. Kaneka Medix Corp (Japan)
        • 6.4.15.1. Business Overview
        • 6.4.15.2. Products/Services Offerings
        • 6.4.15.3. Financial Analysis
        • 6.4.15.4. SWOT Analysis
  • 7. Global Blood Purification Devices Sale, by Type, Application, Mobility, End-Use and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Blood Purification Devices (Value)
      • 7.2.1. Global Blood Purification Devices by: Type (Value)
        • 7.2.1.1. Hemodialysis Device
        • 7.2.1.2. Blood Filtration Device
        • 7.2.1.3. Continuous Renal Replacement Therapy (CRRT) Device
        • 7.2.1.4. Hemoperfusion Device
        • 7.2.1.5. Plasma Exchange Device
      • 7.2.2. Global Blood Purification Devices by: Application (Value)
        • 7.2.2.1. Hospitals & Clinics
        • 7.2.2.2. Dialysis Centers
        • 7.2.2.3. Others
      • 7.2.3. Global Blood Purification Devices by: Mobility (Value)
        • 7.2.3.1. Portable
        • 7.2.3.2. Stationary
      • 7.2.4. Global Blood Purification Devices by: End-Use (Value)
        • 7.2.4.1. Sepsis
        • 7.2.4.2. COVID-19
        • 7.2.4.3. Infectious Diseases
        • 7.2.4.4. Acute Kidney Injury
        • 7.2.4.5. Others
      • 7.2.5. Global Blood Purification Devices Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Blood Purification Devices (Volume)
      • 7.3.1. Global Blood Purification Devices by: Type (Volume)
        • 7.3.1.1. Hemodialysis Device
        • 7.3.1.2. Blood Filtration Device
        • 7.3.1.3. Continuous Renal Replacement Therapy (CRRT) Device
        • 7.3.1.4. Hemoperfusion Device
        • 7.3.1.5. Plasma Exchange Device
      • 7.3.2. Global Blood Purification Devices by: Application (Volume)
        • 7.3.2.1. Hospitals & Clinics
        • 7.3.2.2. Dialysis Centers
        • 7.3.2.3. Others
      • 7.3.3. Global Blood Purification Devices by: Mobility (Volume)
        • 7.3.3.1. Portable
        • 7.3.3.2. Stationary
      • 7.3.4. Global Blood Purification Devices by: End-Use (Volume)
        • 7.3.4.1. Sepsis
        • 7.3.4.2. COVID-19
        • 7.3.4.3. Infectious Diseases
        • 7.3.4.4. Acute Kidney Injury
        • 7.3.4.5. Others
      • 7.3.5. Global Blood Purification Devices Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Blood Purification Devices (Price)
      • 7.4.1. Global Blood Purification Devices by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Blood Purification Devices: by Type(USD Million)
  • Table 2. Blood Purification Devices Hemodialysis Device , by Region USD Million (2015-2020)
  • Table 3. Blood Purification Devices Blood Filtration Device , by Region USD Million (2015-2020)
  • Table 4. Blood Purification Devices Continuous Renal Replacement Therapy (CRRT) Device , by Region USD Million (2015-2020)
  • Table 5. Blood Purification Devices Hemoperfusion Device , by Region USD Million (2015-2020)
  • Table 6. Blood Purification Devices Plasma Exchange Device , by Region USD Million (2015-2020)
  • Table 7. Blood Purification Devices: by Application(USD Million)
  • Table 8. Blood Purification Devices Hospitals & Clinics , by Region USD Million (2015-2020)
  • Table 9. Blood Purification Devices Dialysis Centers , by Region USD Million (2015-2020)
  • Table 10. Blood Purification Devices Others , by Region USD Million (2015-2020)
  • Table 11. Blood Purification Devices: by Mobility(USD Million)
  • Table 12. Blood Purification Devices Portable , by Region USD Million (2015-2020)
  • Table 13. Blood Purification Devices Stationary , by Region USD Million (2015-2020)
  • Table 14. Blood Purification Devices: by End-Use(USD Million)
  • Table 15. Blood Purification Devices Sepsis , by Region USD Million (2015-2020)
  • Table 16. Blood Purification Devices COVID-19 , by Region USD Million (2015-2020)
  • Table 17. Blood Purification Devices Infectious Diseases , by Region USD Million (2015-2020)
  • Table 18. Blood Purification Devices Acute Kidney Injury , by Region USD Million (2015-2020)
  • Table 19. Blood Purification Devices Others , by Region USD Million (2015-2020)
  • Table 20. South America Blood Purification Devices, by Country USD Million (2015-2020)
  • Table 21. South America Blood Purification Devices, by Type USD Million (2015-2020)
  • Table 22. South America Blood Purification Devices, by Application USD Million (2015-2020)
  • Table 23. South America Blood Purification Devices, by Mobility USD Million (2015-2020)
  • Table 24. South America Blood Purification Devices, by End-Use USD Million (2015-2020)
  • Table 25. Brazil Blood Purification Devices, by Type USD Million (2015-2020)
  • Table 26. Brazil Blood Purification Devices, by Application USD Million (2015-2020)
  • Table 27. Brazil Blood Purification Devices, by Mobility USD Million (2015-2020)
  • Table 28. Brazil Blood Purification Devices, by End-Use USD Million (2015-2020)
  • Table 29. Argentina Blood Purification Devices, by Type USD Million (2015-2020)
  • Table 30. Argentina Blood Purification Devices, by Application USD Million (2015-2020)
  • Table 31. Argentina Blood Purification Devices, by Mobility USD Million (2015-2020)
  • Table 32. Argentina Blood Purification Devices, by End-Use USD Million (2015-2020)
  • Table 33. Rest of South America Blood Purification Devices, by Type USD Million (2015-2020)
  • Table 34. Rest of South America Blood Purification Devices, by Application USD Million (2015-2020)
  • Table 35. Rest of South America Blood Purification Devices, by Mobility USD Million (2015-2020)
  • Table 36. Rest of South America Blood Purification Devices, by End-Use USD Million (2015-2020)
  • Table 37. Asia Pacific Blood Purification Devices, by Country USD Million (2015-2020)
  • Table 38. Asia Pacific Blood Purification Devices, by Type USD Million (2015-2020)
  • Table 39. Asia Pacific Blood Purification Devices, by Application USD Million (2015-2020)
  • Table 40. Asia Pacific Blood Purification Devices, by Mobility USD Million (2015-2020)
  • Table 41. Asia Pacific Blood Purification Devices, by End-Use USD Million (2015-2020)
  • Table 42. China Blood Purification Devices, by Type USD Million (2015-2020)
  • Table 43. China Blood Purification Devices, by Application USD Million (2015-2020)
  • Table 44. China Blood Purification Devices, by Mobility USD Million (2015-2020)
  • Table 45. China Blood Purification Devices, by End-Use USD Million (2015-2020)
  • Table 46. Japan Blood Purification Devices, by Type USD Million (2015-2020)
  • Table 47. Japan Blood Purification Devices, by Application USD Million (2015-2020)
  • Table 48. Japan Blood Purification Devices, by Mobility USD Million (2015-2020)
  • Table 49. Japan Blood Purification Devices, by End-Use USD Million (2015-2020)
  • Table 50. India Blood Purification Devices, by Type USD Million (2015-2020)
  • Table 51. India Blood Purification Devices, by Application USD Million (2015-2020)
  • Table 52. India Blood Purification Devices, by Mobility USD Million (2015-2020)
  • Table 53. India Blood Purification Devices, by End-Use USD Million (2015-2020)
  • Table 54. South Korea Blood Purification Devices, by Type USD Million (2015-2020)
  • Table 55. South Korea Blood Purification Devices, by Application USD Million (2015-2020)
  • Table 56. South Korea Blood Purification Devices, by Mobility USD Million (2015-2020)
  • Table 57. South Korea Blood Purification Devices, by End-Use USD Million (2015-2020)
  • Table 58. Taiwan Blood Purification Devices, by Type USD Million (2015-2020)
  • Table 59. Taiwan Blood Purification Devices, by Application USD Million (2015-2020)
  • Table 60. Taiwan Blood Purification Devices, by Mobility USD Million (2015-2020)
  • Table 61. Taiwan Blood Purification Devices, by End-Use USD Million (2015-2020)
  • Table 62. Australia Blood Purification Devices, by Type USD Million (2015-2020)
  • Table 63. Australia Blood Purification Devices, by Application USD Million (2015-2020)
  • Table 64. Australia Blood Purification Devices, by Mobility USD Million (2015-2020)
  • Table 65. Australia Blood Purification Devices, by End-Use USD Million (2015-2020)
  • Table 66. Rest of Asia-Pacific Blood Purification Devices, by Type USD Million (2015-2020)
  • Table 67. Rest of Asia-Pacific Blood Purification Devices, by Application USD Million (2015-2020)
  • Table 68. Rest of Asia-Pacific Blood Purification Devices, by Mobility USD Million (2015-2020)
  • Table 69. Rest of Asia-Pacific Blood Purification Devices, by End-Use USD Million (2015-2020)
  • Table 70. Europe Blood Purification Devices, by Country USD Million (2015-2020)
  • Table 71. Europe Blood Purification Devices, by Type USD Million (2015-2020)
  • Table 72. Europe Blood Purification Devices, by Application USD Million (2015-2020)
  • Table 73. Europe Blood Purification Devices, by Mobility USD Million (2015-2020)
  • Table 74. Europe Blood Purification Devices, by End-Use USD Million (2015-2020)
  • Table 75. Germany Blood Purification Devices, by Type USD Million (2015-2020)
  • Table 76. Germany Blood Purification Devices, by Application USD Million (2015-2020)
  • Table 77. Germany Blood Purification Devices, by Mobility USD Million (2015-2020)
  • Table 78. Germany Blood Purification Devices, by End-Use USD Million (2015-2020)
  • Table 79. France Blood Purification Devices, by Type USD Million (2015-2020)
  • Table 80. France Blood Purification Devices, by Application USD Million (2015-2020)
  • Table 81. France Blood Purification Devices, by Mobility USD Million (2015-2020)
  • Table 82. France Blood Purification Devices, by End-Use USD Million (2015-2020)
  • Table 83. Italy Blood Purification Devices, by Type USD Million (2015-2020)
  • Table 84. Italy Blood Purification Devices, by Application USD Million (2015-2020)
  • Table 85. Italy Blood Purification Devices, by Mobility USD Million (2015-2020)
  • Table 86. Italy Blood Purification Devices, by End-Use USD Million (2015-2020)
  • Table 87. United Kingdom Blood Purification Devices, by Type USD Million (2015-2020)
  • Table 88. United Kingdom Blood Purification Devices, by Application USD Million (2015-2020)
  • Table 89. United Kingdom Blood Purification Devices, by Mobility USD Million (2015-2020)
  • Table 90. United Kingdom Blood Purification Devices, by End-Use USD Million (2015-2020)
  • Table 91. Netherlands Blood Purification Devices, by Type USD Million (2015-2020)
  • Table 92. Netherlands Blood Purification Devices, by Application USD Million (2015-2020)
  • Table 93. Netherlands Blood Purification Devices, by Mobility USD Million (2015-2020)
  • Table 94. Netherlands Blood Purification Devices, by End-Use USD Million (2015-2020)
  • Table 95. Rest of Europe Blood Purification Devices, by Type USD Million (2015-2020)
  • Table 96. Rest of Europe Blood Purification Devices, by Application USD Million (2015-2020)
  • Table 97. Rest of Europe Blood Purification Devices, by Mobility USD Million (2015-2020)
  • Table 98. Rest of Europe Blood Purification Devices, by End-Use USD Million (2015-2020)
  • Table 99. MEA Blood Purification Devices, by Country USD Million (2015-2020)
  • Table 100. MEA Blood Purification Devices, by Type USD Million (2015-2020)
  • Table 101. MEA Blood Purification Devices, by Application USD Million (2015-2020)
  • Table 102. MEA Blood Purification Devices, by Mobility USD Million (2015-2020)
  • Table 103. MEA Blood Purification Devices, by End-Use USD Million (2015-2020)
  • Table 104. Middle East Blood Purification Devices, by Type USD Million (2015-2020)
  • Table 105. Middle East Blood Purification Devices, by Application USD Million (2015-2020)
  • Table 106. Middle East Blood Purification Devices, by Mobility USD Million (2015-2020)
  • Table 107. Middle East Blood Purification Devices, by End-Use USD Million (2015-2020)
  • Table 108. Africa Blood Purification Devices, by Type USD Million (2015-2020)
  • Table 109. Africa Blood Purification Devices, by Application USD Million (2015-2020)
  • Table 110. Africa Blood Purification Devices, by Mobility USD Million (2015-2020)
  • Table 111. Africa Blood Purification Devices, by End-Use USD Million (2015-2020)
  • Table 112. North America Blood Purification Devices, by Country USD Million (2015-2020)
  • Table 113. North America Blood Purification Devices, by Type USD Million (2015-2020)
  • Table 114. North America Blood Purification Devices, by Application USD Million (2015-2020)
  • Table 115. North America Blood Purification Devices, by Mobility USD Million (2015-2020)
  • Table 116. North America Blood Purification Devices, by End-Use USD Million (2015-2020)
  • Table 117. United States Blood Purification Devices, by Type USD Million (2015-2020)
  • Table 118. United States Blood Purification Devices, by Application USD Million (2015-2020)
  • Table 119. United States Blood Purification Devices, by Mobility USD Million (2015-2020)
  • Table 120. United States Blood Purification Devices, by End-Use USD Million (2015-2020)
  • Table 121. Canada Blood Purification Devices, by Type USD Million (2015-2020)
  • Table 122. Canada Blood Purification Devices, by Application USD Million (2015-2020)
  • Table 123. Canada Blood Purification Devices, by Mobility USD Million (2015-2020)
  • Table 124. Canada Blood Purification Devices, by End-Use USD Million (2015-2020)
  • Table 125. Mexico Blood Purification Devices, by Type USD Million (2015-2020)
  • Table 126. Mexico Blood Purification Devices, by Application USD Million (2015-2020)
  • Table 127. Mexico Blood Purification Devices, by Mobility USD Million (2015-2020)
  • Table 128. Mexico Blood Purification Devices, by End-Use USD Million (2015-2020)
  • Table 129. Blood Purification Devices Sales: by Type(K Units)
  • Table 130. Blood Purification Devices Sales Hemodialysis Device , by Region K Units (2015-2020)
  • Table 131. Blood Purification Devices Sales Blood Filtration Device , by Region K Units (2015-2020)
  • Table 132. Blood Purification Devices Sales Continuous Renal Replacement Therapy (CRRT) Device , by Region K Units (2015-2020)
  • Table 133. Blood Purification Devices Sales Hemoperfusion Device , by Region K Units (2015-2020)
  • Table 134. Blood Purification Devices Sales Plasma Exchange Device , by Region K Units (2015-2020)
  • Table 135. Blood Purification Devices Sales: by Application(K Units)
  • Table 136. Blood Purification Devices Sales Hospitals & Clinics , by Region K Units (2015-2020)
  • Table 137. Blood Purification Devices Sales Dialysis Centers , by Region K Units (2015-2020)
  • Table 138. Blood Purification Devices Sales Others , by Region K Units (2015-2020)
  • Table 139. Blood Purification Devices Sales: by Mobility(K Units)
  • Table 140. Blood Purification Devices Sales Portable , by Region K Units (2015-2020)
  • Table 141. Blood Purification Devices Sales Stationary , by Region K Units (2015-2020)
  • Table 142. Blood Purification Devices Sales: by End-Use(K Units)
  • Table 143. Blood Purification Devices Sales Sepsis , by Region K Units (2015-2020)
  • Table 144. Blood Purification Devices Sales COVID-19 , by Region K Units (2015-2020)
  • Table 145. Blood Purification Devices Sales Infectious Diseases , by Region K Units (2015-2020)
  • Table 146. Blood Purification Devices Sales Acute Kidney Injury , by Region K Units (2015-2020)
  • Table 147. Blood Purification Devices Sales Others , by Region K Units (2015-2020)
  • Table 148. South America Blood Purification Devices Sales, by Country K Units (2015-2020)
  • Table 149. South America Blood Purification Devices Sales, by Type K Units (2015-2020)
  • Table 150. South America Blood Purification Devices Sales, by Application K Units (2015-2020)
  • Table 151. South America Blood Purification Devices Sales, by Mobility K Units (2015-2020)
  • Table 152. South America Blood Purification Devices Sales, by End-Use K Units (2015-2020)
  • Table 153. Brazil Blood Purification Devices Sales, by Type K Units (2015-2020)
  • Table 154. Brazil Blood Purification Devices Sales, by Application K Units (2015-2020)
  • Table 155. Brazil Blood Purification Devices Sales, by Mobility K Units (2015-2020)
  • Table 156. Brazil Blood Purification Devices Sales, by End-Use K Units (2015-2020)
  • Table 157. Argentina Blood Purification Devices Sales, by Type K Units (2015-2020)
  • Table 158. Argentina Blood Purification Devices Sales, by Application K Units (2015-2020)
  • Table 159. Argentina Blood Purification Devices Sales, by Mobility K Units (2015-2020)
  • Table 160. Argentina Blood Purification Devices Sales, by End-Use K Units (2015-2020)
  • Table 161. Rest of South America Blood Purification Devices Sales, by Type K Units (2015-2020)
  • Table 162. Rest of South America Blood Purification Devices Sales, by Application K Units (2015-2020)
  • Table 163. Rest of South America Blood Purification Devices Sales, by Mobility K Units (2015-2020)
  • Table 164. Rest of South America Blood Purification Devices Sales, by End-Use K Units (2015-2020)
  • Table 165. Asia Pacific Blood Purification Devices Sales, by Country K Units (2015-2020)
  • Table 166. Asia Pacific Blood Purification Devices Sales, by Type K Units (2015-2020)
  • Table 167. Asia Pacific Blood Purification Devices Sales, by Application K Units (2015-2020)
  • Table 168. Asia Pacific Blood Purification Devices Sales, by Mobility K Units (2015-2020)
  • Table 169. Asia Pacific Blood Purification Devices Sales, by End-Use K Units (2015-2020)
  • Table 170. China Blood Purification Devices Sales, by Type K Units (2015-2020)
  • Table 171. China Blood Purification Devices Sales, by Application K Units (2015-2020)
  • Table 172. China Blood Purification Devices Sales, by Mobility K Units (2015-2020)
  • Table 173. China Blood Purification Devices Sales, by End-Use K Units (2015-2020)
  • Table 174. Japan Blood Purification Devices Sales, by Type K Units (2015-2020)
  • Table 175. Japan Blood Purification Devices Sales, by Application K Units (2015-2020)
  • Table 176. Japan Blood Purification Devices Sales, by Mobility K Units (2015-2020)
  • Table 177. Japan Blood Purification Devices Sales, by End-Use K Units (2015-2020)
  • Table 178. India Blood Purification Devices Sales, by Type K Units (2015-2020)
  • Table 179. India Blood Purification Devices Sales, by Application K Units (2015-2020)
  • Table 180. India Blood Purification Devices Sales, by Mobility K Units (2015-2020)
  • Table 181. India Blood Purification Devices Sales, by End-Use K Units (2015-2020)
  • Table 182. South Korea Blood Purification Devices Sales, by Type K Units (2015-2020)
  • Table 183. South Korea Blood Purification Devices Sales, by Application K Units (2015-2020)
  • Table 184. South Korea Blood Purification Devices Sales, by Mobility K Units (2015-2020)
  • Table 185. South Korea Blood Purification Devices Sales, by End-Use K Units (2015-2020)
  • Table 186. Taiwan Blood Purification Devices Sales, by Type K Units (2015-2020)
  • Table 187. Taiwan Blood Purification Devices Sales, by Application K Units (2015-2020)
  • Table 188. Taiwan Blood Purification Devices Sales, by Mobility K Units (2015-2020)
  • Table 189. Taiwan Blood Purification Devices Sales, by End-Use K Units (2015-2020)
  • Table 190. Australia Blood Purification Devices Sales, by Type K Units (2015-2020)
  • Table 191. Australia Blood Purification Devices Sales, by Application K Units (2015-2020)
  • Table 192. Australia Blood Purification Devices Sales, by Mobility K Units (2015-2020)
  • Table 193. Australia Blood Purification Devices Sales, by End-Use K Units (2015-2020)
  • Table 194. Rest of Asia-Pacific Blood Purification Devices Sales, by Type K Units (2015-2020)
  • Table 195. Rest of Asia-Pacific Blood Purification Devices Sales, by Application K Units (2015-2020)
  • Table 196. Rest of Asia-Pacific Blood Purification Devices Sales, by Mobility K Units (2015-2020)
  • Table 197. Rest of Asia-Pacific Blood Purification Devices Sales, by End-Use K Units (2015-2020)
  • Table 198. Europe Blood Purification Devices Sales, by Country K Units (2015-2020)
  • Table 199. Europe Blood Purification Devices Sales, by Type K Units (2015-2020)
  • Table 200. Europe Blood Purification Devices Sales, by Application K Units (2015-2020)
  • Table 201. Europe Blood Purification Devices Sales, by Mobility K Units (2015-2020)
  • Table 202. Europe Blood Purification Devices Sales, by End-Use K Units (2015-2020)
  • Table 203. Germany Blood Purification Devices Sales, by Type K Units (2015-2020)
  • Table 204. Germany Blood Purification Devices Sales, by Application K Units (2015-2020)
  • Table 205. Germany Blood Purification Devices Sales, by Mobility K Units (2015-2020)
  • Table 206. Germany Blood Purification Devices Sales, by End-Use K Units (2015-2020)
  • Table 207. France Blood Purification Devices Sales, by Type K Units (2015-2020)
  • Table 208. France Blood Purification Devices Sales, by Application K Units (2015-2020)
  • Table 209. France Blood Purification Devices Sales, by Mobility K Units (2015-2020)
  • Table 210. France Blood Purification Devices Sales, by End-Use K Units (2015-2020)
  • Table 211. Italy Blood Purification Devices Sales, by Type K Units (2015-2020)
  • Table 212. Italy Blood Purification Devices Sales, by Application K Units (2015-2020)
  • Table 213. Italy Blood Purification Devices Sales, by Mobility K Units (2015-2020)
  • Table 214. Italy Blood Purification Devices Sales, by End-Use K Units (2015-2020)
  • Table 215. United Kingdom Blood Purification Devices Sales, by Type K Units (2015-2020)
  • Table 216. United Kingdom Blood Purification Devices Sales, by Application K Units (2015-2020)
  • Table 217. United Kingdom Blood Purification Devices Sales, by Mobility K Units (2015-2020)
  • Table 218. United Kingdom Blood Purification Devices Sales, by End-Use K Units (2015-2020)
  • Table 219. Netherlands Blood Purification Devices Sales, by Type K Units (2015-2020)
  • Table 220. Netherlands Blood Purification Devices Sales, by Application K Units (2015-2020)
  • Table 221. Netherlands Blood Purification Devices Sales, by Mobility K Units (2015-2020)
  • Table 222. Netherlands Blood Purification Devices Sales, by End-Use K Units (2015-2020)
  • Table 223. Rest of Europe Blood Purification Devices Sales, by Type K Units (2015-2020)
  • Table 224. Rest of Europe Blood Purification Devices Sales, by Application K Units (2015-2020)
  • Table 225. Rest of Europe Blood Purification Devices Sales, by Mobility K Units (2015-2020)
  • Table 226. Rest of Europe Blood Purification Devices Sales, by End-Use K Units (2015-2020)
  • Table 227. MEA Blood Purification Devices Sales, by Country K Units (2015-2020)
  • Table 228. MEA Blood Purification Devices Sales, by Type K Units (2015-2020)
  • Table 229. MEA Blood Purification Devices Sales, by Application K Units (2015-2020)
  • Table 230. MEA Blood Purification Devices Sales, by Mobility K Units (2015-2020)
  • Table 231. MEA Blood Purification Devices Sales, by End-Use K Units (2015-2020)
  • Table 232. Middle East Blood Purification Devices Sales, by Type K Units (2015-2020)
  • Table 233. Middle East Blood Purification Devices Sales, by Application K Units (2015-2020)
  • Table 234. Middle East Blood Purification Devices Sales, by Mobility K Units (2015-2020)
  • Table 235. Middle East Blood Purification Devices Sales, by End-Use K Units (2015-2020)
  • Table 236. Africa Blood Purification Devices Sales, by Type K Units (2015-2020)
  • Table 237. Africa Blood Purification Devices Sales, by Application K Units (2015-2020)
  • Table 238. Africa Blood Purification Devices Sales, by Mobility K Units (2015-2020)
  • Table 239. Africa Blood Purification Devices Sales, by End-Use K Units (2015-2020)
  • Table 240. North America Blood Purification Devices Sales, by Country K Units (2015-2020)
  • Table 241. North America Blood Purification Devices Sales, by Type K Units (2015-2020)
  • Table 242. North America Blood Purification Devices Sales, by Application K Units (2015-2020)
  • Table 243. North America Blood Purification Devices Sales, by Mobility K Units (2015-2020)
  • Table 244. North America Blood Purification Devices Sales, by End-Use K Units (2015-2020)
  • Table 245. United States Blood Purification Devices Sales, by Type K Units (2015-2020)
  • Table 246. United States Blood Purification Devices Sales, by Application K Units (2015-2020)
  • Table 247. United States Blood Purification Devices Sales, by Mobility K Units (2015-2020)
  • Table 248. United States Blood Purification Devices Sales, by End-Use K Units (2015-2020)
  • Table 249. Canada Blood Purification Devices Sales, by Type K Units (2015-2020)
  • Table 250. Canada Blood Purification Devices Sales, by Application K Units (2015-2020)
  • Table 251. Canada Blood Purification Devices Sales, by Mobility K Units (2015-2020)
  • Table 252. Canada Blood Purification Devices Sales, by End-Use K Units (2015-2020)
  • Table 253. Mexico Blood Purification Devices Sales, by Type K Units (2015-2020)
  • Table 254. Mexico Blood Purification Devices Sales, by Application K Units (2015-2020)
  • Table 255. Mexico Blood Purification Devices Sales, by Mobility K Units (2015-2020)
  • Table 256. Mexico Blood Purification Devices Sales, by End-Use K Units (2015-2020)
  • Table 257. Blood Purification Devices: by Type(USD/Units)
  • Table 258. Company Basic Information, Sales Area and Its Competitors
  • Table 259. Company Basic Information, Sales Area and Its Competitors
  • Table 260. Company Basic Information, Sales Area and Its Competitors
  • Table 261. Company Basic Information, Sales Area and Its Competitors
  • Table 262. Company Basic Information, Sales Area and Its Competitors
  • Table 263. Company Basic Information, Sales Area and Its Competitors
  • Table 264. Company Basic Information, Sales Area and Its Competitors
  • Table 265. Company Basic Information, Sales Area and Its Competitors
  • Table 266. Company Basic Information, Sales Area and Its Competitors
  • Table 267. Company Basic Information, Sales Area and Its Competitors
  • Table 268. Company Basic Information, Sales Area and Its Competitors
  • Table 269. Company Basic Information, Sales Area and Its Competitors
  • Table 270. Company Basic Information, Sales Area and Its Competitors
  • Table 271. Company Basic Information, Sales Area and Its Competitors
  • Table 272. Company Basic Information, Sales Area and Its Competitors
  • Table 273. Blood Purification Devices: by Type(USD Million)
  • Table 274. Blood Purification Devices Hemodialysis Device , by Region USD Million (2021-2026)
  • Table 275. Blood Purification Devices Blood Filtration Device , by Region USD Million (2021-2026)
  • Table 276. Blood Purification Devices Continuous Renal Replacement Therapy (CRRT) Device , by Region USD Million (2021-2026)
  • Table 277. Blood Purification Devices Hemoperfusion Device , by Region USD Million (2021-2026)
  • Table 278. Blood Purification Devices Plasma Exchange Device , by Region USD Million (2021-2026)
  • Table 279. Blood Purification Devices: by Application(USD Million)
  • Table 280. Blood Purification Devices Hospitals & Clinics , by Region USD Million (2021-2026)
  • Table 281. Blood Purification Devices Dialysis Centers , by Region USD Million (2021-2026)
  • Table 282. Blood Purification Devices Others , by Region USD Million (2021-2026)
  • Table 283. Blood Purification Devices: by Mobility(USD Million)
  • Table 284. Blood Purification Devices Portable , by Region USD Million (2021-2026)
  • Table 285. Blood Purification Devices Stationary , by Region USD Million (2021-2026)
  • Table 286. Blood Purification Devices: by End-Use(USD Million)
  • Table 287. Blood Purification Devices Sepsis , by Region USD Million (2021-2026)
  • Table 288. Blood Purification Devices COVID-19 , by Region USD Million (2021-2026)
  • Table 289. Blood Purification Devices Infectious Diseases , by Region USD Million (2021-2026)
  • Table 290. Blood Purification Devices Acute Kidney Injury , by Region USD Million (2021-2026)
  • Table 291. Blood Purification Devices Others , by Region USD Million (2021-2026)
  • Table 292. South America Blood Purification Devices, by Country USD Million (2021-2026)
  • Table 293. South America Blood Purification Devices, by Type USD Million (2021-2026)
  • Table 294. South America Blood Purification Devices, by Application USD Million (2021-2026)
  • Table 295. South America Blood Purification Devices, by Mobility USD Million (2021-2026)
  • Table 296. South America Blood Purification Devices, by End-Use USD Million (2021-2026)
  • Table 297. Brazil Blood Purification Devices, by Type USD Million (2021-2026)
  • Table 298. Brazil Blood Purification Devices, by Application USD Million (2021-2026)
  • Table 299. Brazil Blood Purification Devices, by Mobility USD Million (2021-2026)
  • Table 300. Brazil Blood Purification Devices, by End-Use USD Million (2021-2026)
  • Table 301. Argentina Blood Purification Devices, by Type USD Million (2021-2026)
  • Table 302. Argentina Blood Purification Devices, by Application USD Million (2021-2026)
  • Table 303. Argentina Blood Purification Devices, by Mobility USD Million (2021-2026)
  • Table 304. Argentina Blood Purification Devices, by End-Use USD Million (2021-2026)
  • Table 305. Rest of South America Blood Purification Devices, by Type USD Million (2021-2026)
  • Table 306. Rest of South America Blood Purification Devices, by Application USD Million (2021-2026)
  • Table 307. Rest of South America Blood Purification Devices, by Mobility USD Million (2021-2026)
  • Table 308. Rest of South America Blood Purification Devices, by End-Use USD Million (2021-2026)
  • Table 309. Asia Pacific Blood Purification Devices, by Country USD Million (2021-2026)
  • Table 310. Asia Pacific Blood Purification Devices, by Type USD Million (2021-2026)
  • Table 311. Asia Pacific Blood Purification Devices, by Application USD Million (2021-2026)
  • Table 312. Asia Pacific Blood Purification Devices, by Mobility USD Million (2021-2026)
  • Table 313. Asia Pacific Blood Purification Devices, by End-Use USD Million (2021-2026)
  • Table 314. China Blood Purification Devices, by Type USD Million (2021-2026)
  • Table 315. China Blood Purification Devices, by Application USD Million (2021-2026)
  • Table 316. China Blood Purification Devices, by Mobility USD Million (2021-2026)
  • Table 317. China Blood Purification Devices, by End-Use USD Million (2021-2026)
  • Table 318. Japan Blood Purification Devices, by Type USD Million (2021-2026)
  • Table 319. Japan Blood Purification Devices, by Application USD Million (2021-2026)
  • Table 320. Japan Blood Purification Devices, by Mobility USD Million (2021-2026)
  • Table 321. Japan Blood Purification Devices, by End-Use USD Million (2021-2026)
  • Table 322. India Blood Purification Devices, by Type USD Million (2021-2026)
  • Table 323. India Blood Purification Devices, by Application USD Million (2021-2026)
  • Table 324. India Blood Purification Devices, by Mobility USD Million (2021-2026)
  • Table 325. India Blood Purification Devices, by End-Use USD Million (2021-2026)
  • Table 326. South Korea Blood Purification Devices, by Type USD Million (2021-2026)
  • Table 327. South Korea Blood Purification Devices, by Application USD Million (2021-2026)
  • Table 328. South Korea Blood Purification Devices, by Mobility USD Million (2021-2026)
  • Table 329. South Korea Blood Purification Devices, by End-Use USD Million (2021-2026)
  • Table 330. Taiwan Blood Purification Devices, by Type USD Million (2021-2026)
  • Table 331. Taiwan Blood Purification Devices, by Application USD Million (2021-2026)
  • Table 332. Taiwan Blood Purification Devices, by Mobility USD Million (2021-2026)
  • Table 333. Taiwan Blood Purification Devices, by End-Use USD Million (2021-2026)
  • Table 334. Australia Blood Purification Devices, by Type USD Million (2021-2026)
  • Table 335. Australia Blood Purification Devices, by Application USD Million (2021-2026)
  • Table 336. Australia Blood Purification Devices, by Mobility USD Million (2021-2026)
  • Table 337. Australia Blood Purification Devices, by End-Use USD Million (2021-2026)
  • Table 338. Rest of Asia-Pacific Blood Purification Devices, by Type USD Million (2021-2026)
  • Table 339. Rest of Asia-Pacific Blood Purification Devices, by Application USD Million (2021-2026)
  • Table 340. Rest of Asia-Pacific Blood Purification Devices, by Mobility USD Million (2021-2026)
  • Table 341. Rest of Asia-Pacific Blood Purification Devices, by End-Use USD Million (2021-2026)
  • Table 342. Europe Blood Purification Devices, by Country USD Million (2021-2026)
  • Table 343. Europe Blood Purification Devices, by Type USD Million (2021-2026)
  • Table 344. Europe Blood Purification Devices, by Application USD Million (2021-2026)
  • Table 345. Europe Blood Purification Devices, by Mobility USD Million (2021-2026)
  • Table 346. Europe Blood Purification Devices, by End-Use USD Million (2021-2026)
  • Table 347. Germany Blood Purification Devices, by Type USD Million (2021-2026)
  • Table 348. Germany Blood Purification Devices, by Application USD Million (2021-2026)
  • Table 349. Germany Blood Purification Devices, by Mobility USD Million (2021-2026)
  • Table 350. Germany Blood Purification Devices, by End-Use USD Million (2021-2026)
  • Table 351. France Blood Purification Devices, by Type USD Million (2021-2026)
  • Table 352. France Blood Purification Devices, by Application USD Million (2021-2026)
  • Table 353. France Blood Purification Devices, by Mobility USD Million (2021-2026)
  • Table 354. France Blood Purification Devices, by End-Use USD Million (2021-2026)
  • Table 355. Italy Blood Purification Devices, by Type USD Million (2021-2026)
  • Table 356. Italy Blood Purification Devices, by Application USD Million (2021-2026)
  • Table 357. Italy Blood Purification Devices, by Mobility USD Million (2021-2026)
  • Table 358. Italy Blood Purification Devices, by End-Use USD Million (2021-2026)
  • Table 359. United Kingdom Blood Purification Devices, by Type USD Million (2021-2026)
  • Table 360. United Kingdom Blood Purification Devices, by Application USD Million (2021-2026)
  • Table 361. United Kingdom Blood Purification Devices, by Mobility USD Million (2021-2026)
  • Table 362. United Kingdom Blood Purification Devices, by End-Use USD Million (2021-2026)
  • Table 363. Netherlands Blood Purification Devices, by Type USD Million (2021-2026)
  • Table 364. Netherlands Blood Purification Devices, by Application USD Million (2021-2026)
  • Table 365. Netherlands Blood Purification Devices, by Mobility USD Million (2021-2026)
  • Table 366. Netherlands Blood Purification Devices, by End-Use USD Million (2021-2026)
  • Table 367. Rest of Europe Blood Purification Devices, by Type USD Million (2021-2026)
  • Table 368. Rest of Europe Blood Purification Devices, by Application USD Million (2021-2026)
  • Table 369. Rest of Europe Blood Purification Devices, by Mobility USD Million (2021-2026)
  • Table 370. Rest of Europe Blood Purification Devices, by End-Use USD Million (2021-2026)
  • Table 371. MEA Blood Purification Devices, by Country USD Million (2021-2026)
  • Table 372. MEA Blood Purification Devices, by Type USD Million (2021-2026)
  • Table 373. MEA Blood Purification Devices, by Application USD Million (2021-2026)
  • Table 374. MEA Blood Purification Devices, by Mobility USD Million (2021-2026)
  • Table 375. MEA Blood Purification Devices, by End-Use USD Million (2021-2026)
  • Table 376. Middle East Blood Purification Devices, by Type USD Million (2021-2026)
  • Table 377. Middle East Blood Purification Devices, by Application USD Million (2021-2026)
  • Table 378. Middle East Blood Purification Devices, by Mobility USD Million (2021-2026)
  • Table 379. Middle East Blood Purification Devices, by End-Use USD Million (2021-2026)
  • Table 380. Africa Blood Purification Devices, by Type USD Million (2021-2026)
  • Table 381. Africa Blood Purification Devices, by Application USD Million (2021-2026)
  • Table 382. Africa Blood Purification Devices, by Mobility USD Million (2021-2026)
  • Table 383. Africa Blood Purification Devices, by End-Use USD Million (2021-2026)
  • Table 384. North America Blood Purification Devices, by Country USD Million (2021-2026)
  • Table 385. North America Blood Purification Devices, by Type USD Million (2021-2026)
  • Table 386. North America Blood Purification Devices, by Application USD Million (2021-2026)
  • Table 387. North America Blood Purification Devices, by Mobility USD Million (2021-2026)
  • Table 388. North America Blood Purification Devices, by End-Use USD Million (2021-2026)
  • Table 389. United States Blood Purification Devices, by Type USD Million (2021-2026)
  • Table 390. United States Blood Purification Devices, by Application USD Million (2021-2026)
  • Table 391. United States Blood Purification Devices, by Mobility USD Million (2021-2026)
  • Table 392. United States Blood Purification Devices, by End-Use USD Million (2021-2026)
  • Table 393. Canada Blood Purification Devices, by Type USD Million (2021-2026)
  • Table 394. Canada Blood Purification Devices, by Application USD Million (2021-2026)
  • Table 395. Canada Blood Purification Devices, by Mobility USD Million (2021-2026)
  • Table 396. Canada Blood Purification Devices, by End-Use USD Million (2021-2026)
  • Table 397. Mexico Blood Purification Devices, by Type USD Million (2021-2026)
  • Table 398. Mexico Blood Purification Devices, by Application USD Million (2021-2026)
  • Table 399. Mexico Blood Purification Devices, by Mobility USD Million (2021-2026)
  • Table 400. Mexico Blood Purification Devices, by End-Use USD Million (2021-2026)
  • Table 401. Blood Purification Devices Sales: by Type(K Units)
  • Table 402. Blood Purification Devices Sales Hemodialysis Device , by Region K Units (2021-2026)
  • Table 403. Blood Purification Devices Sales Blood Filtration Device , by Region K Units (2021-2026)
  • Table 404. Blood Purification Devices Sales Continuous Renal Replacement Therapy (CRRT) Device , by Region K Units (2021-2026)
  • Table 405. Blood Purification Devices Sales Hemoperfusion Device , by Region K Units (2021-2026)
  • Table 406. Blood Purification Devices Sales Plasma Exchange Device , by Region K Units (2021-2026)
  • Table 407. Blood Purification Devices Sales: by Application(K Units)
  • Table 408. Blood Purification Devices Sales Hospitals & Clinics , by Region K Units (2021-2026)
  • Table 409. Blood Purification Devices Sales Dialysis Centers , by Region K Units (2021-2026)
  • Table 410. Blood Purification Devices Sales Others , by Region K Units (2021-2026)
  • Table 411. Blood Purification Devices Sales: by Mobility(K Units)
  • Table 412. Blood Purification Devices Sales Portable , by Region K Units (2021-2026)
  • Table 413. Blood Purification Devices Sales Stationary , by Region K Units (2021-2026)
  • Table 414. Blood Purification Devices Sales: by End-Use(K Units)
  • Table 415. Blood Purification Devices Sales Sepsis , by Region K Units (2021-2026)
  • Table 416. Blood Purification Devices Sales COVID-19 , by Region K Units (2021-2026)
  • Table 417. Blood Purification Devices Sales Infectious Diseases , by Region K Units (2021-2026)
  • Table 418. Blood Purification Devices Sales Acute Kidney Injury , by Region K Units (2021-2026)
  • Table 419. Blood Purification Devices Sales Others , by Region K Units (2021-2026)
  • Table 420. South America Blood Purification Devices Sales, by Country K Units (2021-2026)
  • Table 421. South America Blood Purification Devices Sales, by Type K Units (2021-2026)
  • Table 422. South America Blood Purification Devices Sales, by Application K Units (2021-2026)
  • Table 423. South America Blood Purification Devices Sales, by Mobility K Units (2021-2026)
  • Table 424. South America Blood Purification Devices Sales, by End-Use K Units (2021-2026)
  • Table 425. Brazil Blood Purification Devices Sales, by Type K Units (2021-2026)
  • Table 426. Brazil Blood Purification Devices Sales, by Application K Units (2021-2026)
  • Table 427. Brazil Blood Purification Devices Sales, by Mobility K Units (2021-2026)
  • Table 428. Brazil Blood Purification Devices Sales, by End-Use K Units (2021-2026)
  • Table 429. Argentina Blood Purification Devices Sales, by Type K Units (2021-2026)
  • Table 430. Argentina Blood Purification Devices Sales, by Application K Units (2021-2026)
  • Table 431. Argentina Blood Purification Devices Sales, by Mobility K Units (2021-2026)
  • Table 432. Argentina Blood Purification Devices Sales, by End-Use K Units (2021-2026)
  • Table 433. Rest of South America Blood Purification Devices Sales, by Type K Units (2021-2026)
  • Table 434. Rest of South America Blood Purification Devices Sales, by Application K Units (2021-2026)
  • Table 435. Rest of South America Blood Purification Devices Sales, by Mobility K Units (2021-2026)
  • Table 436. Rest of South America Blood Purification Devices Sales, by End-Use K Units (2021-2026)
  • Table 437. Asia Pacific Blood Purification Devices Sales, by Country K Units (2021-2026)
  • Table 438. Asia Pacific Blood Purification Devices Sales, by Type K Units (2021-2026)
  • Table 439. Asia Pacific Blood Purification Devices Sales, by Application K Units (2021-2026)
  • Table 440. Asia Pacific Blood Purification Devices Sales, by Mobility K Units (2021-2026)
  • Table 441. Asia Pacific Blood Purification Devices Sales, by End-Use K Units (2021-2026)
  • Table 442. China Blood Purification Devices Sales, by Type K Units (2021-2026)
  • Table 443. China Blood Purification Devices Sales, by Application K Units (2021-2026)
  • Table 444. China Blood Purification Devices Sales, by Mobility K Units (2021-2026)
  • Table 445. China Blood Purification Devices Sales, by End-Use K Units (2021-2026)
  • Table 446. Japan Blood Purification Devices Sales, by Type K Units (2021-2026)
  • Table 447. Japan Blood Purification Devices Sales, by Application K Units (2021-2026)
  • Table 448. Japan Blood Purification Devices Sales, by Mobility K Units (2021-2026)
  • Table 449. Japan Blood Purification Devices Sales, by End-Use K Units (2021-2026)
  • Table 450. India Blood Purification Devices Sales, by Type K Units (2021-2026)
  • Table 451. India Blood Purification Devices Sales, by Application K Units (2021-2026)
  • Table 452. India Blood Purification Devices Sales, by Mobility K Units (2021-2026)
  • Table 453. India Blood Purification Devices Sales, by End-Use K Units (2021-2026)
  • Table 454. South Korea Blood Purification Devices Sales, by Type K Units (2021-2026)
  • Table 455. South Korea Blood Purification Devices Sales, by Application K Units (2021-2026)
  • Table 456. South Korea Blood Purification Devices Sales, by Mobility K Units (2021-2026)
  • Table 457. South Korea Blood Purification Devices Sales, by End-Use K Units (2021-2026)
  • Table 458. Taiwan Blood Purification Devices Sales, by Type K Units (2021-2026)
  • Table 459. Taiwan Blood Purification Devices Sales, by Application K Units (2021-2026)
  • Table 460. Taiwan Blood Purification Devices Sales, by Mobility K Units (2021-2026)
  • Table 461. Taiwan Blood Purification Devices Sales, by End-Use K Units (2021-2026)
  • Table 462. Australia Blood Purification Devices Sales, by Type K Units (2021-2026)
  • Table 463. Australia Blood Purification Devices Sales, by Application K Units (2021-2026)
  • Table 464. Australia Blood Purification Devices Sales, by Mobility K Units (2021-2026)
  • Table 465. Australia Blood Purification Devices Sales, by End-Use K Units (2021-2026)
  • Table 466. Rest of Asia-Pacific Blood Purification Devices Sales, by Type K Units (2021-2026)
  • Table 467. Rest of Asia-Pacific Blood Purification Devices Sales, by Application K Units (2021-2026)
  • Table 468. Rest of Asia-Pacific Blood Purification Devices Sales, by Mobility K Units (2021-2026)
  • Table 469. Rest of Asia-Pacific Blood Purification Devices Sales, by End-Use K Units (2021-2026)
  • Table 470. Europe Blood Purification Devices Sales, by Country K Units (2021-2026)
  • Table 471. Europe Blood Purification Devices Sales, by Type K Units (2021-2026)
  • Table 472. Europe Blood Purification Devices Sales, by Application K Units (2021-2026)
  • Table 473. Europe Blood Purification Devices Sales, by Mobility K Units (2021-2026)
  • Table 474. Europe Blood Purification Devices Sales, by End-Use K Units (2021-2026)
  • Table 475. Germany Blood Purification Devices Sales, by Type K Units (2021-2026)
  • Table 476. Germany Blood Purification Devices Sales, by Application K Units (2021-2026)
  • Table 477. Germany Blood Purification Devices Sales, by Mobility K Units (2021-2026)
  • Table 478. Germany Blood Purification Devices Sales, by End-Use K Units (2021-2026)
  • Table 479. France Blood Purification Devices Sales, by Type K Units (2021-2026)
  • Table 480. France Blood Purification Devices Sales, by Application K Units (2021-2026)
  • Table 481. France Blood Purification Devices Sales, by Mobility K Units (2021-2026)
  • Table 482. France Blood Purification Devices Sales, by End-Use K Units (2021-2026)
  • Table 483. Italy Blood Purification Devices Sales, by Type K Units (2021-2026)
  • Table 484. Italy Blood Purification Devices Sales, by Application K Units (2021-2026)
  • Table 485. Italy Blood Purification Devices Sales, by Mobility K Units (2021-2026)
  • Table 486. Italy Blood Purification Devices Sales, by End-Use K Units (2021-2026)
  • Table 487. United Kingdom Blood Purification Devices Sales, by Type K Units (2021-2026)
  • Table 488. United Kingdom Blood Purification Devices Sales, by Application K Units (2021-2026)
  • Table 489. United Kingdom Blood Purification Devices Sales, by Mobility K Units (2021-2026)
  • Table 490. United Kingdom Blood Purification Devices Sales, by End-Use K Units (2021-2026)
  • Table 491. Netherlands Blood Purification Devices Sales, by Type K Units (2021-2026)
  • Table 492. Netherlands Blood Purification Devices Sales, by Application K Units (2021-2026)
  • Table 493. Netherlands Blood Purification Devices Sales, by Mobility K Units (2021-2026)
  • Table 494. Netherlands Blood Purification Devices Sales, by End-Use K Units (2021-2026)
  • Table 495. Rest of Europe Blood Purification Devices Sales, by Type K Units (2021-2026)
  • Table 496. Rest of Europe Blood Purification Devices Sales, by Application K Units (2021-2026)
  • Table 497. Rest of Europe Blood Purification Devices Sales, by Mobility K Units (2021-2026)
  • Table 498. Rest of Europe Blood Purification Devices Sales, by End-Use K Units (2021-2026)
  • Table 499. MEA Blood Purification Devices Sales, by Country K Units (2021-2026)
  • Table 500. MEA Blood Purification Devices Sales, by Type K Units (2021-2026)
  • Table 501. MEA Blood Purification Devices Sales, by Application K Units (2021-2026)
  • Table 502. MEA Blood Purification Devices Sales, by Mobility K Units (2021-2026)
  • Table 503. MEA Blood Purification Devices Sales, by End-Use K Units (2021-2026)
  • Table 504. Middle East Blood Purification Devices Sales, by Type K Units (2021-2026)
  • Table 505. Middle East Blood Purification Devices Sales, by Application K Units (2021-2026)
  • Table 506. Middle East Blood Purification Devices Sales, by Mobility K Units (2021-2026)
  • Table 507. Middle East Blood Purification Devices Sales, by End-Use K Units (2021-2026)
  • Table 508. Africa Blood Purification Devices Sales, by Type K Units (2021-2026)
  • Table 509. Africa Blood Purification Devices Sales, by Application K Units (2021-2026)
  • Table 510. Africa Blood Purification Devices Sales, by Mobility K Units (2021-2026)
  • Table 511. Africa Blood Purification Devices Sales, by End-Use K Units (2021-2026)
  • Table 512. North America Blood Purification Devices Sales, by Country K Units (2021-2026)
  • Table 513. North America Blood Purification Devices Sales, by Type K Units (2021-2026)
  • Table 514. North America Blood Purification Devices Sales, by Application K Units (2021-2026)
  • Table 515. North America Blood Purification Devices Sales, by Mobility K Units (2021-2026)
  • Table 516. North America Blood Purification Devices Sales, by End-Use K Units (2021-2026)
  • Table 517. United States Blood Purification Devices Sales, by Type K Units (2021-2026)
  • Table 518. United States Blood Purification Devices Sales, by Application K Units (2021-2026)
  • Table 519. United States Blood Purification Devices Sales, by Mobility K Units (2021-2026)
  • Table 520. United States Blood Purification Devices Sales, by End-Use K Units (2021-2026)
  • Table 521. Canada Blood Purification Devices Sales, by Type K Units (2021-2026)
  • Table 522. Canada Blood Purification Devices Sales, by Application K Units (2021-2026)
  • Table 523. Canada Blood Purification Devices Sales, by Mobility K Units (2021-2026)
  • Table 524. Canada Blood Purification Devices Sales, by End-Use K Units (2021-2026)
  • Table 525. Mexico Blood Purification Devices Sales, by Type K Units (2021-2026)
  • Table 526. Mexico Blood Purification Devices Sales, by Application K Units (2021-2026)
  • Table 527. Mexico Blood Purification Devices Sales, by Mobility K Units (2021-2026)
  • Table 528. Mexico Blood Purification Devices Sales, by End-Use K Units (2021-2026)
  • Table 529. Blood Purification Devices: by Type(USD/Units)
  • Table 530. Research Programs/Design for This Report
  • Table 531. Key Data Information from Secondary Sources
  • Table 532. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Blood Purification Devices: by Type USD Million (2015-2020)
  • Figure 5. Global Blood Purification Devices: by Application USD Million (2015-2020)
  • Figure 6. Global Blood Purification Devices: by Mobility USD Million (2015-2020)
  • Figure 7. Global Blood Purification Devices: by End-Use USD Million (2015-2020)
  • Figure 8. South America Blood Purification Devices Share (%), by Country
  • Figure 9. Asia Pacific Blood Purification Devices Share (%), by Country
  • Figure 10. Europe Blood Purification Devices Share (%), by Country
  • Figure 11. MEA Blood Purification Devices Share (%), by Country
  • Figure 12. North America Blood Purification Devices Share (%), by Country
  • Figure 13. Global Blood Purification Devices: by Type K Units (2015-2020)
  • Figure 14. Global Blood Purification Devices: by Application K Units (2015-2020)
  • Figure 15. Global Blood Purification Devices: by Mobility K Units (2015-2020)
  • Figure 16. Global Blood Purification Devices: by End-Use K Units (2015-2020)
  • Figure 17. South America Blood Purification Devices Share (%), by Country
  • Figure 18. Asia Pacific Blood Purification Devices Share (%), by Country
  • Figure 19. Europe Blood Purification Devices Share (%), by Country
  • Figure 20. MEA Blood Purification Devices Share (%), by Country
  • Figure 21. North America Blood Purification Devices Share (%), by Country
  • Figure 22. Global Blood Purification Devices: by Type USD/Units (2015-2020)
  • Figure 23. Global Blood Purification Devices share by Players 2020 (%)
  • Figure 24. Global Blood Purification Devices share by Players (Top 3) 2020(%)
  • Figure 25. Global Blood Purification Devices share by Players (Top 5) 2020(%)
  • Figure 26. BCG Matrix for key Companies
  • Figure 27. Asahi Kasei Medical (Japan) Revenue, Net Income and Gross profit
  • Figure 28. Asahi Kasei Medical (Japan) Revenue: by Geography 2020
  • Figure 29. Haemonetics (United States) Revenue, Net Income and Gross profit
  • Figure 30. Haemonetics (United States) Revenue: by Geography 2020
  • Figure 31. Toray Industries, Inc. (Japan) Revenue, Net Income and Gross profit
  • Figure 32. Toray Industries, Inc. (Japan) Revenue: by Geography 2020
  • Figure 33. Macopharma (France) Revenue, Net Income and Gross profit
  • Figure 34. Macopharma (France) Revenue: by Geography 2020
  • Figure 35. Cytosorbents Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 36. Cytosorbents Corporation (United States) Revenue: by Geography 2020
  • Figure 37. Baxter International, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 38. Baxter International, Inc. (United States) Revenue: by Geography 2020
  • Figure 39. B. Braun Melsungen AG (Germany) Revenue, Net Income and Gross profit
  • Figure 40. B. Braun Melsungen AG (Germany) Revenue: by Geography 2020
  • Figure 41. ExThera Medical Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 42. ExThera Medical Corporation (United States) Revenue: by Geography 2020
  • Figure 43. Medtronic plc (Bellco) (Ireland) Revenue, Net Income and Gross profit
  • Figure 44. Medtronic plc (Bellco) (Ireland) Revenue: by Geography 2020
  • Figure 45. Aethlon Medical, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 46. Aethlon Medical, Inc. (United States) Revenue: by Geography 2020
  • Figure 47. Fresenius SE & Co. KGaA (Germany) Revenue, Net Income and Gross profit
  • Figure 48. Fresenius SE & Co. KGaA (Germany) Revenue: by Geography 2020
  • Figure 49. Cerus Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 50. Cerus Corporation (United States) Revenue: by Geography 2020
  • Figure 51. Jafron Biomedical Co., Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 52. Jafron Biomedical Co., Ltd. (China) Revenue: by Geography 2020
  • Figure 53. Spectra Medical, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 54. Spectra Medical, Inc. (United States) Revenue: by Geography 2020
  • Figure 55. Kaneka Medix Corp (Japan) Revenue, Net Income and Gross profit
  • Figure 56. Kaneka Medix Corp (Japan) Revenue: by Geography 2020
  • Figure 57. Global Blood Purification Devices: by Type USD Million (2021-2026)
  • Figure 58. Global Blood Purification Devices: by Application USD Million (2021-2026)
  • Figure 59. Global Blood Purification Devices: by Mobility USD Million (2021-2026)
  • Figure 60. Global Blood Purification Devices: by End-Use USD Million (2021-2026)
  • Figure 61. South America Blood Purification Devices Share (%), by Country
  • Figure 62. Asia Pacific Blood Purification Devices Share (%), by Country
  • Figure 63. Europe Blood Purification Devices Share (%), by Country
  • Figure 64. MEA Blood Purification Devices Share (%), by Country
  • Figure 65. North America Blood Purification Devices Share (%), by Country
  • Figure 66. Global Blood Purification Devices: by Type K Units (2021-2026)
  • Figure 67. Global Blood Purification Devices: by Application K Units (2021-2026)
  • Figure 68. Global Blood Purification Devices: by Mobility K Units (2021-2026)
  • Figure 69. Global Blood Purification Devices: by End-Use K Units (2021-2026)
  • Figure 70. South America Blood Purification Devices Share (%), by Country
  • Figure 71. Asia Pacific Blood Purification Devices Share (%), by Country
  • Figure 72. Europe Blood Purification Devices Share (%), by Country
  • Figure 73. MEA Blood Purification Devices Share (%), by Country
  • Figure 74. North America Blood Purification Devices Share (%), by Country
  • Figure 75. Global Blood Purification Devices: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Asahi Kasei Medical (Japan)
  • Haemonetics (United States)
  • Toray Industries, Inc. (Japan)
  • Macopharma (France)
  • Cytosorbents Corporation (United States)
  • Baxter International, Inc. (United States)
  • B. Braun Melsungen AG (Germany)
  • ExThera Medical Corporation (United States)
  • Medtronic plc (Bellco) (Ireland)
  • Aethlon Medical, Inc. (United States)
  • Fresenius SE & Co. KGaA (Germany)
  • Cerus Corporation (United States)
  • Jafron Biomedical Co., Ltd. (China)
  • Spectra Medical, Inc. (United States)
  • Kaneka Medix Corp (Japan)
Additional players considered in the study are as follows:
Nikkiso Co, Ltd. (Japan) , Shandong Zhongbaokang (China) , Nanjing Shuangwei (China)
Select User Access Type

Key Highlights of Report


Jan 2021 240 Pages 92 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Blood Purification Devices Market Quantitative research analysis
Global Blood Purification Devices Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

"The High Prevalence of Patients Suffering With Chronic Kidney Diseases " is seen as one of major growth factors of Blood Purification Devices Market in years to come.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.

Know More About Global Blood Purification Devices Market Report?

Have a Query? Click Here

Other Related Reports

Embolic Protection Device Comprehensive Study by Type (Distal Filter Devices, Distal Occlusion Devices, Proximal Occlusion Devices), Application (Cardiovascular Diseases, Neurovascular Diseases, Peri...
$ 3750
Minimally Invasive Glaucoma Surgery (MIGS) Devices Comprehensive Study by Target (Trabecular Meshwork, Suprachoroidal Space, Others), Surgery (Glaucoma in Conjunction with Cataract, Stand-Alone Glauc...
$ 3450
Optical Colposcopy Comprehensive Study by Application (Cervical Cancer Diagnostic, Physical Examination, Other), End User (Hospitals, Gynecology Clinics, Diagnostic Center, Research & Academics) Play...
$ 3500
Spinal Fusion Devices Comprehensive Study by Type (Cervical Devices, Thoracolumbar Devices, Interbody Devices, Biologics), Application (Degenerative Disc Disease, Complex Deformity, Traumas & Fractur...
$ 3750
Medical Surgical Lasers Comprehensive Study by Type (Diode Lasers, Solid-State Lasers, Gas Lasers, Dye Lasers), Application (Ophthalmology, Urology, Gynaecology, Dermatology, Dental, Cardiology, Onco...
$ 3450
Centesis Catheters Comprehensive Study by Type (Small-bore CentesisCatheters, Large-bore Centesis Catheters), Application (Short-term Drainage Procedures, Percutaneous Fluid Aspirations), Distributio...
$ 3750